Keywords: Spectroscopy, High-Field MRI
Motivation: We want to explore the potential benefits that high-field MRSI can provide added value by allowing for higher spectral resolution of metabolites.
Goal(s): Our goal was to test the robustness of 7T-CRT-FID-MRSI in the characterization of epilepsy, in particular with respect to glutamate and glutamine.
Approach: We measured 42 patients with focal epilepsy using 7T-CRT-FID-MRSI. The obtained metabolites were normalized to ratios of NAA and tCr and concentration estimates of glutamate and glutamine were related to seizure frequency.
Results: We could demonstrate that high-field MRSI shows high sensitivity in identifying epileptic zones as well as a correlation of glutamate/glutamine ratios to seizure frequency.
Impact: 7T-CRT-FID MRSI shows high potential for identifying metabolic alterations in epilepsy. Additionally, due to higher spectral resolution, we could demonstrate a correlation of seizure frequency to the glutamate/glutamine ratio, potentially aiding in quantification of seizure burden in clinical practice.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords